Multiple sclerosis is a disease in which the immune system erroneously attacks a protective insulation that surrounds neurons ...
New Scientist on MSN
This virus infects most of us – but why do only some get very ill?
The ubiquitous Epstein-Barr virus is increasingly being linked to conditions like multiple sclerosis and lupus. But why do ...
Scientists have identified 22 genes that explain why one common virus leaves many people unharmed but puts others at risk of ...
The immune system's reaction to the common Epstein-Barr virus can ultimately damage the brain and contribute to multiple sclerosis (MS), according to new research from Karolinska Institutet, published ...
The study's findings suggest that health outcomes reflect a complex interaction between genes, lifestyle, and viral history ...
By understanding who is most at risk, scientists might be able to better target treatments. Read more at straitstimes.com. Read more at straitstimes.com.
The immune system’s reaction to the common Epstein-Barr virus can ultimately damage the brain and contribute to multiple sclerosis (MS). This is shown by new research from Karolinska Institutet, ...
News-Medical.Net on MSN
Epstein-Barr virus together with a gene variant contributes to onset of multiple sclerosis
One of the leading triggers for multiple sclerosis (MS) is an infection with the Epstein-Barr virus. However, certain gene variants also play an important role. Researchers at the University of Zurich ...
News-Medical.Net on MSN
Rare immune events link Epstein Barr virus to early multiple sclerosis damage
Autoimmune diseases such as multiple sclerosis arise when the immune system turns against the body itself. Yet for most of them, it remains unclear why this process begins. Researchers have now ...
Researchers have developed a groundbreaking vaccine that generates immunity against the Epstein-Barr virus, a virus that almost all of us carry and which has been found to be a primary cause of ...
Epstein-Barr is among the most common viruses, but no vaccines are available to prevent its infection. Merck is joining the pursuit for a vaccine by striking a deal with Opko Health, paying $50 ...
OXFORD, England & CAMBRIDGE, Mass.--(BUSINESS WIRE)--SpyBiotech, a biotechnology company with novel vaccine platform technologies that can target infectious diseases, cancer, and chronic diseases, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results